Promising Targeted Therapy, Padcev, Falls Short of Meeting Goals for Advanced Breast Cancer But May Still Have a Future Treating the Disease

Research presents at the ASCO Annual Meeting indicates that a promising targeted therapy did not meet clinical trial goals in advanced metastatic breast cancer.